Intravitreal fluocinolone acetonide implant for the treatment of persistent post-surgical cystoid macular edema in vitrectomized eyes
We present four clinical cases of post-surgical CME (three following vitrectomy and one following cataract surgery in a vitrectomized eye 2 years ago). All of them had been previously treated with an average of four injections of intravitreal dexamethasone implant (Ozurdex®), with repeated recurrence of CME. After treatment with Iluvien, three cases showed improvement of both visual acuity and macular anatomy, with resolution of the macular edema. One patient required additional treatment with Ozurdex during follow-up, further improving CME. Two of the cases required topical pressure lowering treatment, and none required filtering surgery. Iluvien could be an effective therapeutic option for persistent non-diabetic macular edema after vitrectomy or cataract surgery refractory to other intravitreal therapies, with the benefit of being able to provide longer recurrence-free periods.PMID:34836464 | DOI:10.1177/11206721211046718
Source: European Journal of Ophthalmology - Category: Opthalmology Authors: Lucia Miguel-Escuder Álvaro Olate-Pérez Anna Sala-Puigdoners Aina Moll-Udina Marc Figueras-Roca Manuel Javier Navarro-Angulo Alfredo Ad án Laura Pelegr ín Source Type: research
More News: Anatomy | Cataract Removal | Cataracts | Corticosteroid Therapy | Dexamethasone | Diabetes | Endocrinology | Eye Implants | Eyes | Opthalmology